USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: Aviv Biomedical, Inc.
City: LAKEWOOD
State: NJ
Zip+4: -
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: (732) 370-1300

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $170,158.00 1
SBIR Phase II $826,992.00 1
STTR Phase I $99,973.00 1

Award List:

Advanced Absorbance Detection for the AUC

Award Year / Program / Phase: 2005 / STTR / Phase I
Agency: HHS
Research Institution: UNIVERSITY OF NEW HAMPSHIRE
Principal Investigator: Glen D. Ramsay
Award Amount: $99,973.00
RI Contact: N/A
Abstract:
DESCRIPTION (provided by applicant): The purpose of this STTR is to produce a commercially available rapid-scan absorbance optical detection system for XLA/I analytical ultracentrifuges. The currently available absorbance optical system provided by the analytical ultracentrifuge manufacturer is not… More

Point-of Care System for Determination of Bilirubin Capacity in Neonates

Award Year / Program / Phase: 2010 / SBIR / Phase I
Agency: HHS
Principal Investigator: Glen D. Ramsay
Award Amount: $170,158.00
Abstract:
DESCRIPTION (provided by applicant): Human serum albumin is capable of binding bilirubin with high affinity, thus sequestering it and mitigat- ing its harmful neurological effects in jaundiced newborns. Despite considerable work indicating that the level o f bilirubin in the blood relative to the… More

Point-of Care System for Determination of Bilirubin Capacity in Neonates

Award Year / Program / Phase: 2012 / SBIR / Phase II
Agency: HHS
Principal Investigator: Glen D. Ramsay – 732-370-1300
Award Amount: $826,992.00
Abstract:
DESCRIPTION (provided by applicant): Uncontrolled hyperbilirubinemia (jaundice) in neonates has long been known to lead to neurological dysfunction including irreversible athetoid cerebral palsy with speech, ocular and hearing impairments, and even death.Contemporary management is based upon… More